Suppliers / BrightGene Bio-Medical

BrightGene Bio-Medical

China 688166.SS 21 employees reconciled across 8 public records · 4 entities Updated 9 July 2026

BrightGene Bio-Medical is an API manufacturer based in China. It holds 41 active US drug master files and 3 valid CEPs. Its filings concentrate with MINSA (CR) and US FDA. Its GMP standing is certified by EMA, MFDS (Korea) and US FDA. Its most recent recorded inspection, by US FDA, closed on 20 January 2024 as VAI.

41
active US DMFs
3
valid CEPs
4
registered plants 1 with an FDA FEI number
8
filings across 2 regulators

Inspection history

  • 20 January 2024 VAI US FDA
  • 25 September 2015 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Suzhou, China Not on file
China, China 3011254184
Taizhou, China Not on file
Suzhou, China Not on file

What they file, and where

Molecule Regulators Docs
Micafungin SFDA (Saudi Arabia), US FDA 4
Caspofungin SFDA (Saudi Arabia), US FDA 3
Dalbavancin SFDA (Saudi Arabia), US FDA 3
Entecavir EDQM, SFDA (Saudi Arabia), US FDA 3
Everolimus EDQM, US FDA 3
Posaconazole US FDA 3
Sugammadex SFDA (Saudi Arabia), US FDA 3
Argatroban PMDA (Japan) 3
Anidulafungin SFDA (Saudi Arabia), US FDA 2
Fidaxomicin US FDA 2
Show all 31 molecules on file
Fondaparinux US FDA 2
Oseltamivir EDQM, US FDA 2
Pimecrolimus US FDA 2
Saxagliptin US FDA 2
(21R)-Argatroban US FDA 1
Carboprost US FDA 1
Eribulin US FDA 1
Exatecan US FDA 1
Ferric Carboxymaltose US FDA 1
Isavuconazonium US FDA 1
Lurbinectedin US FDA 1
Molnupiravir US FDA 1
Pemetrexed US FDA 1
Sirolimus US FDA 1
Trabectedin US FDA 1
Voclosporin US FDA 1
エリブリンメシル酸塩 PMDA (Japan) 1
スガマデクスナトリウム PMDA (Japan) 1
ミカファンギンナトリウム PMDA (Japan) 1
ミカファンギンナトリウム(Tmc) PMDA (Japan) 1
Argatroban(Ag-B1) PMDA (Japan) 1

Also appears on these molecule pages

Show 10 more molecule pages

Filings and GMP by regulator

Regulator Filings GMP certificates
MINSA (CR) 7 None
US FDA 1 1
EMA None 6
MFDS (Korea) None 2

Questions about BrightGene Bio-Medical

Does BrightGene Bio-Medical hold a US DMF or a CEP?
BrightGene Bio-Medical holds 41 active US drug master files and 3 valid CEPs. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is BrightGene Bio-Medical FDA-registered?
One site operated by BrightGene Bio-Medical carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did BrightGene Bio-Medical's last inspection go?
The most recent inspection on record closed on 20 January 2024 as VAI (Voluntary Action Indicated: issues were found but did not warrant regulatory action). 2 inspections are on file.
Where does BrightGene Bio-Medical manufacture?
4 registered sites are on record, in China (Suzhou, China and Taizhou among others). Every site is listed on this page with the register it came from.
What does BrightGene Bio-Medical make?
31 molecules are on record against BrightGene Bio-Medical, including Micafungin, Caspofungin, Dalbavancin and Entecavir. Each links through to that molecule's full manufacturer list.
Which regulators recognise BrightGene Bio-Medical's GMP?
Current GMP certificates are on record from EMA, MFDS (Korea) and US FDA. GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. BrightGene Bio-Medical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 20 January 2024.

Comparable suppliers

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates